CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-07 | Snodgres Jon Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +466 | 2,108 | ||
| 2022-09-09 | DAWES KAREN A Director | Sale | −775 | $227.17 | $176K | 76,401 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Option exercise | +10,000 | $33.87 | $339K | 204,667 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −824 | $220.08 | $181K | 203,843 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −1,235 | $221.46 | $274K | 202,608 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −720 | $222.24 | $160K | 201,888 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −1,389 | $223.26 | $310K | 200,499 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −6,626 | $224.47 | $1.5M | 193,873 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −10,490 | $225.22 | $2.4M | 183,383 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −4,873 | $226.34 | $1.1M | 178,510 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Sale | −245 | $227.01 | $56K | 178,265 |
| 2022-09-08 | Hunt Anthony Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | +10,000 | 59,246 | ||
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Option exercise | +3,047 | $86.10 | $262K | 40,234 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Option exercise | +970 | $215.58 | $209K | 41,204 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Sale | −4,298 | $252.70 | $1.1M | 36,906 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Sale | −2,400 | $253.16 | $608K | 34,506 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +3,047 | 1,524 | ||
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +970 | 1,940 | ||
| 2022-08-11 | KURIYEL RALF Senior VP, R&D | Option exercise | +2,000 | $33.05 | $66K | 22,110 |
| 2022-08-11 | KURIYEL RALF Senior VP, R&D | Option exercise | +1,354 | $59.52 | $81K | 23,464 |
Page 18 of 23 · 455 trades